MANE
Veradermics, Incorporated
NYSE · Healthcare · Biotechnology · US
$98.51
+0.78%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-9.6%
Return on equity
-9.5%
Return on assets
-10.9%
Return on invested capital
0.00x
Asset turnover
-$62.9M
Cash from operations
$20
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026